We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia

Firmenich is since May 9 2023 part of dsm-firmenich. Please follow us here: https://www.linkedin.com/company/dsm-firmenich

Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition, and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphates and minerals to help our customers offer products that are tasty, healthy, and nutritious. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico, and China.

Elementis is a global specialty chemical company, with 1,300 employees operating 17 manufacturing sites across the globe. At Elementis, we bring a distinctive combination of expertise, innovation, and teamwork to every formulation challenge. We create high-value specialty additives that enhance the performance of our customers' products and make a positive change in the world. Combining our leading positions in the science of materials flow, surface modification, and formulation with access to unique natural materials, Elementis delivers unique chemistry, sustainable solutions to customers in a wide range of markets, including cosmetics, anti-perspirants, decorative and industrial coatings, automotive and ceramics. In 2022 Elementis reported revenue of $736m and adjusted operating profit of $101m.

PMC Group is a growth oriented, diversified, global chemicals company dedicated to innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. Dedicated to sustainability, PMC operates from a global manufacturing, innovation and marketing platform with facilities and personnel in the Americas, Europe and Asia. PMC Group began in 1994 as a vision in the mind of CEO Dr. P.M. Chakrabarti, then Chief Technical Officer of the Fortune 100 chemical powerhouse PPG Industries. The vision was to create a new model for the global corporation, one in which top line and bottom line growth go hand in hand, while promoting social good. The engine for this growth is the profits generated by the organization and the fuel for this engine is innovation. In order to foster innovation, our management structure strives to allow our businesses to operate in the manner most effective to serve their individual markets while having the financial, management and related strengths of global enterprise. Today, through a combination of innovative organic growth coupled with strategic acquisitions, PMC Group has become a global organization with manufacturing, research and marketing organizations throughout the world all fueled by continuous innovation and a dedication to unassailable quality, service and safety of our people and the environment. Our products enhance the quality of life of people in every corner of the globe. Our excitement for this growth has no bounds, and we continue to drive the innovation that has helped to make so many of our customers’ businesses better and helped create a better living for consumers around the world. We welcome your patronage in this journey of ours.

Renaissance is a US-based contract development and manufacturing organization (CDMO) for pharmaceutical and biotech companies. With over 20 years of experience in nasal sprays and sterile injectable dosage forms, we have an unparalleled track record of helping our clients from development through to commercial launch. Core Capabilities: - Aseptic fill-finish development and manufacturing (vials) - Unit-dose and bi-dose nasal spray development and manufacturing - Preserved and Non-preserved multi-dose nasal spray development and manufacturing - Analytical development & testing services - Spray characterization development & testing services - Formulation development & optimization - DEA Schedule I-V products From early-stage development through final production, Renaissance has the expertise and resources you need for success. Visit renpharm.com to learn more.

Gelest, Inc., headquartered in Morrisville, PA, USA, was founded in 1991 to serve the advanced technology applications markets and is recognized worldwide as an innovator, manufacturer and supplier of Organo-Silicon and Metal-Organic materials for commercial production and R&D support. Since its inception, Gelest, Inc. has continuously added experts in the fields of silanes, silicones, and metal-organics. The technical staff includes individuals with extensive hands-on experience and academic credentials (see Management Team). Joint developments between customers and staff have led to an increased product offering from several hundred materials to the current listing of several thousand materials. The company has focused its research and development efforts toward expanding the offering of Group 4A and 4B analogs. Gelest, Inc. offers the most comprehensive selection of silane, silicone, and metal-organic materials in the world

Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page.

We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System™ (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or older. XHANCE was made widely available through commercial channels in April 2018. In March and June 2022, we announced positive top line results from our two Phase 3b clinical trials (ReOpen1 and ReOpen2) of XHANCE for a follow-on indication for the treatment of chronic sinusitis. In February 2023, we submitted a prior approval efficacy supplement (sNDA) to support the approval of a new indication for XHANCE for the treatment of chronic rhinosinusitis. If the sNDA is approved, XHANCE has the potential to be the first drug therapy approved by the FDA for the treatment of chronic sinusitis. As of February 20, 2023, we had a total of 141 full-time employees all of whom are in the United States, and no part-time employees. Culture is a critical element in the management of our organization. Our colleagues are focused on driving our business with the Optinose values as the foundation for all our efforts. Our goal is that each colleague feels a deep connection to what they do, loves coming to work and is aligned to our One Mission – to improve lives. Our values of Authenticity, Fearless Conversations, Friendship, Openness, Perseverance and Possibility Thinking guide our actions and decisions.

ResinTech Inc., an acknowledged leader in ion exchange, manufactures a broad range of ion exchange resins for water and waste water treatment, including deionization,softening, metals removal, product purification, resource recovery, and pollution control. In addition to its ion exchange resins, ResinTech supplies activated carbon and inorganic selective exchangers. ResinTech has developed an application technology resource group that includes state-of-the-art laboratories and a group of scientists dedicated to expanding the frontiers of application technology. This group is put to use whenever product or process recommendations are requested, assuring customers get the most cost-effective approach to achieving their process goals.

Inolex is a fiercely independent company that designs sustainable ingredients for health, beauty, and wellness. We don’t swim with the current; we create it. We envision and realize solutions to advance the needs of our customers. We challenge ourselves and the industry to think differently. Honoring nature, we design emerging technologies that ensure the safe and optimum performance of leading brands in more than 85 countries. Our designers are guided by the Principles of Green Chemistry, to invent the future of sustainable ingredient platforms. By balancing conscious science with nature and artistry, our imaginative approaches become the building blocks for exceptional products that care for people and our planet. We are Inolex. Thinkers, Designers, Creators, and Rebels.

Plant Food Co. provides peace of mind to golf course superintendents and others through its liquid fertilizers and custom plant health solutions.